Complement inhibitors are not useful in secondary hemolytic uremic syndromes
- PMID: 31543154
- DOI: 10.1016/j.kint.2019.08.001
Complement inhibitors are not useful in secondary hemolytic uremic syndromes
Comment in
-
Anticomplement therapies in "secondary thrombotic microangiopathies": ready for prime time?Kidney Int. 2019 Oct;96(4):833-835. doi: 10.1016/j.kint.2019.08.005. Kidney Int. 2019. PMID: 31543155 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
